3/A

OWNERSHIP DOCUMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: August 22, 2013
Period of Report: December 28, 2012
Accession Number: 0001213900-13-004777

View Document ↗ View on SEC.gov ↗